Table 2 Comparison of incidence rate of complications
From: Stenting of the pancreatic duct in the early phase of acute pancreatitis: a retrospective study
Indicator | Study group (N = 46) | Control group (N = 85) | Total (N = 131) | P value |
|---|---|---|---|---|
New-onset organ failure, n (%) | 0.0851 | |||
1 (2.2) | 11 (12.9) | 12 (9.2) | ||
New-onset systemic complications, n (%) | 0.2442 | |||
8 (17.4) | 24 (28.2) | 32 (24.4) | ||
Late local complications, n (%) (0- none; 1- pseudocyst; 2- wall-off necrosis; 3- infectious necrosis) | 0.9592 | |||
0 | 33 (75.0) | 62 (73.8) | 95 (74.2) | |
2 | 4 (9.1) | 9 (10.7) | 13 (10.2) | |
3 | 7 (15.9) | 13 (15.5) | 20 (15.6) | |
Critical complex end point, n (%) (0 = cure; 1 = asymptomatic/symptomatic complications/death) | 0.7012 | |||
0 | 37 (82.2) | 66 (77.6) | 103 (79.2) | |
1 | 8 (17.8) | 19 (22.4) | 27 (20.8) | |